Clinical Trials Directory

Trials / Unknown

UnknownNCT01411748

Comparison of Saccharomyces Boulardii and Nystatin Prophylaxis on Candida Colonization and Infection in Very Low Birth Weight Infants

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
140 (estimated)
Sponsor
Zekai Tahir Burak Women's Health Research and Education Hospital · Academic / Other
Sex
All
Age
1 Day – 90 Days
Healthy volunteers
Not accepted

Summary

Probiotics are favorable microorganisms that regulate the flora of the gastrointestinal system and stimulate the immune system. Saccharomyces boulardii was shown to reduce candida colonization. The objective of this study is to evaluate the efficacy of prophylactic S boulardii in reducing the candida colonization and infection in very low birth weight infants.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTReflor5 million unit/day, orally, beginning on the second day of life, until discharge from hospital
DRUGmikostatin50000 unit/3 times a day, both for orally and by orogastric route

Timeline

Start date
2011-07-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2011-08-08
Last updated
2011-08-08

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT01411748. Inclusion in this directory is not an endorsement.